[Menopause: Hypertension and vascular disease]

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Gerontology

Background:

• Hypertension affects 25% of women and is a primary cardiovascular risk factor.
• Menopause-induced hormone changes exacerbate cardiovascular risks, including arterial stiffness, heart failure, and stroke.
• Physiopathological mechanisms of hypertension and cardiovascular disease in menopausal women remain debated.

Purpose of the Study:

• To analyze physiopathological mechanisms of postmenopausal hypertension.
• To understand vascular aging effects in women post-estrogen decline.
• To explore sex-specific differences in antihypertensive drug responses.

Main Methods:

• Literature review of studies on postmenopausal hypertension.
• Analysis of hormonal influences on cardiovascular health.
• Examination of pharmacokinetic and pharmacodynamic variations between sexes.

Main Results:

• Estrogen decline is linked to increased arterial stiffness and cardiovascular disease.
• Women exhibit distinct adverse effects with common antihypertensive medications.
• Vascular aging processes are accelerated by reduced estrogen levels.

Conclusions:

• Understanding postmenopausal hypertension mechanisms is crucial for women's cardiovascular health.
• Tailoring antihypertensive therapies based on sex-specific responses is essential.
• Further research into estrogen's vascular protective role is warranted.